Long-Term Effects of Rosiglitazone on the Progressive Decline in Renal Function in Patients With Type 2 Diabetes
Mee Kyoung Kim, Seung-Hyun Ko, Ki-Hyun Baek, Yu-Bae Ahn, Kun-Ho Yoon, Moo-Il Kang, Kwang-Woo Lee, Ki-Ho Song
Korean J Intern Med. 2009;24(3):227-232. Published online 2009 Aug 26 DOI: https://doi.org/10.3904/kjim.2009.24.3.227
Citations to this article as recorded by 
The clinical evaluation of combined detection of microcirculation, lipid metabolism, and inflammatory-related factors in the treatment of diabetic nephropathy with atorvastatin
Haicheng Wang, Zhengfang Zhang, Jiali Sun
European Journal of Inflammation.2019;[Epub] CrossRef
Low white blood cell count is independently associated with chronic kidney disease progression in the elderly: the CKD-ROUTE study
Yohei Arai, Eiichiro Kanda, Soichiro Iimori, Shotaro Naito, Yumi Noda, Sei Sasaki, Eisei Sohara, Tomokazu Okado, Tatemitsu Rai, Shinichi Uchida
Clinical and Experimental Nephrology.2018; 22(2): 291. CrossRef
Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study
Yu-Hsin Chen, Der-Cherng Tarng, Harn-Shen Chen, Stephen L Atkin
PLOS ONE.2016; 11(11): e0165750. CrossRef
Antidiabetic therapy in post kidney transplantation diabetes mellitus
Johannes Werzowa, Marcus Säemann, Michael Haidinger, Michael Krebs, Manfred Hecking
Transplantation Reviews.2015; 29(3): 145. CrossRef
Thiazolidinediones and Risk of Long-Term Dialysis in Diabetic Patients with Advanced Chronic Kidney Disease: A Nationwide Cohort Study
Yu-Hsin Chen, Ming-Han Chiang, Jia-Sin Liu, Yu-Kang Chang, Ko-Lin Kuo, Szu-Chun Hung, Hsin-Ling Tai, Chih-Cheng Hsu, Der-Cherng Tarng, Tatsuo Shimosawa
PLOS ONE.2015; 10(6): e0129922. CrossRef
Effects of diabetes on oxidative and nitrosative stress in kidney mitochondria from aged rats
Rocío V. Pérez-Gallardo, Ruth Noriega-Cisneros, Edgar Esquivel-Gutiérrez, Elizabeth Calderón-Cortés, Christian Cortés-Rojo, Salvador Manzo-Avalos, Jesús Campos-García, Rafael Salgado-Garciglia, Rocío Montoya-Pérez, Istvan Boldogh, Alfredo Saavedra-Molina
Journal of Bioenergetics and Biomembranes.2014; 46(6): 511. CrossRef
Association of peroxisome proliferator-activated receptors/retinoic acid receptors with renal diseases
Tian-Biao Zhou, Gregor P. C. Drummen, Zong-Pei Jiang, Yao-Bin Long, Yuan-Han Qin
Journal of Receptors and Signal Transduction.2013; 33(6): 349. CrossRef
Glitazones in chronic kidney disease: Potential and concerns
D. Bolignano, C. Zoccali
Nutrition, Metabolism and Cardiovascular Diseases.2012; 22(3): 167. CrossRef
The role of nuclear receptors in the kidney in obesity and metabolic syndrome
Claudia Tovar-Palacio, Nimbe Torres, Andrea Diaz-Villaseñor, Armando R. Tovar
Genes & Nutrition.2012; 7(4): 483. CrossRef
The role of metabolic and haemodynamic factors in podocyte injury in diabetes
Nicole Stieger, Kirstin Worthmann, Mario Schiffer
Diabetes/Metabolism Research and Reviews.2011; 27(3): 207. CrossRef
Nuclear receptors in renal disease
Moshe Levi
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2011; 1812(8): 1061. CrossRef
Thiazolidinediones in the treatment of patients with Post-Transplant-Hyperglycemia or new-onset diabetes mellitus after renal transplantation (NODAT) – A new therapeutic option?
Marcus D. Säemann, Michael Krebs
Wiener klinische Wochenschrift.2010; 122(7-8): 198. CrossRef